Parietal Cell Antibody (PCA) Immunofluorescence Assay (IFA)

• Test Name: Parietal Cell Antibody (PCA) Immunofluorescence Assay (IFA) Test
• Test Type: Autoantibody detection test
• Specimen Required: Blood serum sample
• Methodology: Indirect immunofluorescence assay (IFA)
• Purpose: Detects autoantibodies against gastric parietal cells, indicative of autoimmune gastritis or pernicious anaemia.

• Diagnosis: Assists in diagnosing autoimmune gastritis and pernicious anaemia.
• Differentiation: Helps differentiate autoimmune causes from other types of gastritis.
• Monitoring: Monitors disease progression and response to treatment in diagnosed patients.
• Screening: Used in screening individuals with a family history of autoimmune disorders.

• Components:
  • Test kit containing slides coated with gastric parietal cells.
  • Fluorescent-labeled anti-human immunoglobulin.
  • Controls for ensuring assay accuracy.
  • Detailed instructions for test performance.
• Procedure:
  • Blood sample collection and serum preparation.
  • Application of serum to antigen-coated slides.
  • Incubation and washing steps.
  • Addition of fluorescent-labeled anti-human immunoglobulin.
  • Observation under a fluorescence microscope for positive staining.

• Positive Result: Indicates the presence of autoantibodies against gastric parietal cells, suggesting autoimmune gastritis or pernicious anaemia.
• Negative Result: Indicates the absence of detectable autoantibodies, making autoimmune gastritis or pernicious anaemia less likely.
• Clinical Correlation: Results should be interpreted alongside clinical history, symptoms, and other diagnostic tests for a comprehensive assessment.
• Titers: Higher antibody titers may correlate with more severe disease.

• Qualitative: Reports as positive or negative based on the presence of fluorescence.
• Quantitative: This may include antibody titer levels to indicate the concentration of autoantibodies.
• Turnaround Time: Typically available within a few days, depending on the laboratory.

Q. What is the Parietal Cell Antibody IFA Test?
The Parietal Cell Antibody IFA Test is a blood test that detects autoantibodies against gastric parietal cells, used to diagnose autoimmune gastritis and pernicious anaemia
 

Q. Who should get the Parietal Cell Antibody IFA Test?
Individuals with symptoms of gastritis, pernicious anaemia, or those with a family history of autoimmune diseases may be recommended this test by their healthcare provider
 

Q. How is the Parietal Cell Antibody IFA Test performed?
A blood sample is collected and the serum is tested in a laboratory using an indirect immunofluorescence assay to detect the presence of autoantibodies against gastric parietal cells
 

Q. What does a positive result on the Parietal Cell Antibody IFA Test mean?
A positive result indicates the presence of autoantibodies against gastric parietal cells, which is suggestive of autoimmune gastritis or pernicious anaemia
 

Q. Are there any preparations needed before taking the Parietal Cell Antibody IFA Test?
No special preparations are needed for this test. However, inform your healthcare provider about any medications or conditions that might affect the test results
 

Q. How long does it take to get results from the Parietal Cell Antibody IFA Test?
Results are typically available within a few days, depending on the laboratory's processing time
 

Q. What should I do if my Parietal Cell Antibody IFA Test result is positive?
If the test result is positive, your healthcare provider may recommend further diagnostic tests, treatment options, and regular monitoring to manage the condition effectively